Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsGet a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORE
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Immunomodulatory therapies based on large or small molecules hold great promise for the treatment of a variety of tumors and autoimmune indications. However, these therapies come with the risk of some side effects. One of the most dangerous side effects of therapy is cytokine release syndrome (CRS). After receiving treatment, patients may experience the release of pro-inflammatory cytokines, which can lead to symptoms from fever and rashes to more serious and life-threatening symptoms such as cardiac arrest or organ failure.
To better study CRS during treatment, quantitative detection and evaluation of cytokines in vitro are particularly important. With our group of expert immunologists, Creative Biolabs is dedicated to performing in vitro cytokine release assays service for global clients to best suit your program requirements.
Creative Biolabs can provide the following measurement methods for our clients, which including but not limited to:
To provide straightforward, end-to-end in vitro cytokine release assay service, our team of highly trained immunologists and technicians will help you work out the best service and manage the whole process from sample handling to final report delivery within several days.
L-2, IL-6, IL-8, IL-10, IL-1β, IL-12p40, IL-17A, IFNγ, MIP-1α and TNF-α
In vitro cytokine, release assay service is performed under strict quality systems. We offer accurate, clearly presented, easy to interpret reports.
We are pleased to use our extensive experience and advanced platforms to provide the optimal and most appropriate experimental scheme to satisfy each demand from our customers. For more information, please contact us or send us an inquiry directly.
Reference
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
